305 related articles for article (PubMed ID: 11878577)
1. Prognostic factors and secondary malignancies in childhood medulloblastoma.
Stavrou T; Bromley CM; Nicholson HS; Byrne J; Packer RJ; Goldstein AM; Reaman GH
J Pediatr Hematol Oncol; 2001 Oct; 23(7):431-6. PubMed ID: 11878577
[TBL] [Abstract][Full Text] [Related]
2. Nevoid basal cell carcinoma syndrome: relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature.
Amlashi SF; Riffaud L; Brassier G; Morandi X
Cancer; 2003 Aug; 98(3):618-24. PubMed ID: 12879481
[TBL] [Abstract][Full Text] [Related]
3. Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961.
Packer RJ; Zhou T; Holmes E; Vezina G; Gajjar A
Neuro Oncol; 2013 Jan; 15(1):97-103. PubMed ID: 23099653
[TBL] [Abstract][Full Text] [Related]
4. The therapeutic outcome of medulloblastoma in 49 children.
Jaing TH; Hung IJ; Yang CP; Wang HS; Hung PC
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(4):279-85. PubMed ID: 7572172
[TBL] [Abstract][Full Text] [Related]
5. Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea.
Yoon JH; Park KD; Kang HJ; Kim H; Lee JW; Kim SK; Wang KC; Park SH; Kim IH; Shin HY
World J Pediatr; 2017 Aug; 13(4):367-373. PubMed ID: 28550392
[TBL] [Abstract][Full Text] [Related]
6. Medulloblastoma--a retrospective analysis.
Awasthy BS; Das Gupta C; Singh R; Patel AK; Julka PK
Indian J Pediatr; 1997; 64(5):693-7. PubMed ID: 10771904
[TBL] [Abstract][Full Text] [Related]
7. Survival and prognostic factors in a series of adults with medulloblastomas.
Riffaud L; Saikali S; Leray E; Hamlat A; Haegelen C; Vauleon E; Lesimple T
J Neurosurg; 2009 Sep; 111(3):478-87. PubMed ID: 19231932
[TBL] [Abstract][Full Text] [Related]
8. Local control in non-metastatic medulloblastoma.
Christopherson KM; Bradley JA; Rotondo RL; Pincus DW; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891
[TBL] [Abstract][Full Text] [Related]
9. Adult medulloblastoma: an analysis of survival and prognostic factors.
Le QT; Weil MD; Wara WM; Lamborn KR; Prados MD; Edwards MS; Gutin PH
Cancer J Sci Am; 1997; 3(4):238-45. PubMed ID: 9263630
[TBL] [Abstract][Full Text] [Related]
10. Importance of radiation time and dose factors on outcome for childhood medulloblastoma.
Back M; Ahern V; Berry M; Borg M; Sexton M; Cameron F; Stevens G; Allison R; Childs J; Barton M
Australas Radiol; 2005 Aug; 49(4):298-303. PubMed ID: 16026436
[TBL] [Abstract][Full Text] [Related]
11. Medulloblastoma.
Zhang R; Zhou L
Chin Med J (Engl); 1999 Apr; 112(4):297-301. PubMed ID: 11593525
[TBL] [Abstract][Full Text] [Related]
12. Late toxicity following craniospinal radiation for early-stage medulloblastoma.
Christopherson KM; Rotondo RL; Bradley JA; Pincus DW; Wynn TT; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Apr; 53(4):471-80. PubMed ID: 24564687
[TBL] [Abstract][Full Text] [Related]
13. Medulloblastoma: long-term results for patients treated with definitive radiation therapy during the computed tomography era.
Merchant TE; Wang MH; Haida T; Lindsley KL; Finlay J; Dunkel IJ; Rosenblum MK; Leibel SA
Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):29-35. PubMed ID: 8823256
[TBL] [Abstract][Full Text] [Related]
14. Secondary manifestation of medulloblastoma: metastases and local recurrences in 66 patients.
Sure U; Bertalanffy H; Isenmann S; Brandner S; Berghorn WJ; Seeger W; Aguzzi A
Acta Neurochir (Wien); 1995; 136(3-4):117-26. PubMed ID: 8748840
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of chemotherapy, radiotherapy dose, and extent of surgical resection in adult medulloblastoma.
Haque W; Verma V; Brian Butler E; Teh BS
J Clin Neurosci; 2020 Jun; 76():154-160. PubMed ID: 32291240
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy and adjuvant chemotherapy for childhood medulloblastoma. The Royal Marsden Hospital experience.
Whitton AC; Syndikus I; Tait DM; Bloom HJ
Strahlenther Onkol; 1995 Nov; 171(11):615-21. PubMed ID: 7502224
[TBL] [Abstract][Full Text] [Related]
17. Medulloblastoma in adults: a series from Brazil.
Malheiros SM; Franco CM; Stávale JN; Santos AJ; Borges LR; Pelaez MP; Ferraz FA; Gabbai AA
J Neurooncol; 2002 Dec; 60(3):247-53. PubMed ID: 12510776
[TBL] [Abstract][Full Text] [Related]
18. Histological variants of medulloblastoma are the most powerful clinical prognostic indicators.
Massimino M; Antonelli M; Gandola L; Miceli R; Pollo B; Biassoni V; Schiavello E; Buttarelli FR; Spreafico F; Collini P; Giangaspero F
Pediatr Blood Cancer; 2013 Feb; 60(2):210-6. PubMed ID: 22693015
[TBL] [Abstract][Full Text] [Related]
19. Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse.
Herrlinger U; Steinbrecher A; Rieger J; Hau P; Kortmann RD; Meyermann R; Schabet M; Bamberg M; Dichgans J; Bogdahn U; Weller M
J Neurol; 2005 Mar; 252(3):291-9. PubMed ID: 16189725
[TBL] [Abstract][Full Text] [Related]
20. Germline SUFU mutation carriers and medulloblastoma: clinical characteristics, cancer risk, and prognosis.
Guerrini-Rousseau L; Dufour C; Varlet P; Masliah-Planchon J; Bourdeaut F; Guillaud-Bataille M; Abbas R; Bertozzi AI; Fouyssac F; Huybrechts S; Puget S; Bressac-De Paillerets B; Caron O; Sevenet N; Dimaria M; Villebasse S; Delattre O; Valteau-Couanet D; Grill J; Brugières L
Neuro Oncol; 2018 Jul; 20(8):1122-1132. PubMed ID: 29186568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
